Ovarian Cancer Clinical Roundup

News Articles

(NCI/Cancer Currents Blog) July 30, 2020 - A microRNA—a molecule made by cells to turn genes on and off—called miR-181a may help high-grade serous ovarian cancer form, a study has found. The scientists think the microRNA could potentially help doctors detect ovarian cancer earlier.
(Yahoo! Finance) July 30, 2020 - Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.
(Celsion) July 27, 2020 - Celsion Corporation, an oncology focused drug-development company, today announced the randomization of the first two patients in the Phase II portion of the Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian cancer.
(Yahoo! Finance) July 23, 2020 - Corcept Therapeutics Inc. today announced the completion of enrollment in its controlled, Phase 2 trial of relacorilant combined with nab-paclitaxel (Abraxane®) in patients with metastatic, platinum-resistant ovarian cancer.
View all ovarian cancer news

Case Studies


Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, and Dr. Kamath, Gynecologic Oncology Fellow, University of Miami, discuss the treatment of platinum sensitive recurrent high-grade serous ovarian cancer

Clinical Roundtables

A panel of three experts, led by Dr. Brian Slomovitz of Sylvester Comprehensive Cancer Center, University of Miami Health System, discussed the expanded role of PARP inhibitors and how the new targeted agents, niraparib, olaparib, and rucaparib, are setting a new paradigm in the treatment of advanced ovarian cancer. Topics covered included a look at three landmark trials from ESMO and how they've influenced treatment regimens, incorporating BRCA and HRD testing on patients, and sequencing PARP inhibitors with and without bevacizumab as part of treatment.

Featured Ovarian Cancer Tweets

Erika P. Hamilton, MD
ErikaHamilton9 - Jul 30  #alpelisib rash management #bcsm https://t.co/GGeEDIdsu3

Pedro T. Ramirez, MD
pedroramirezMD - Jul 29  Learn about #PDL1 and #ovarian #cancer in this article @IJGConline @IJGCfellows @SGO_org @IGCSociety @ESGO_society https://t.co/HgNa7OKDvm

Pedro T. Ramirez, MD
pedroramirezMD - Jul 27  Love to hear everyone’s comments on this great discussion with #HIPEC leader in #ovarian cancer @zivanovicmd Should… https://t.co/YJyXFHgzRh

Elizabeth M. Swisher, MD
SwisherLiz - Jul 16  Looking forward to opening SOROCk @NRGonc trial led by @levinemd and @KPenningtonMD for #OvarianCancerPrevention i… https://t.co/IobxkRyHPS